Stephen Davis - Director at Heron Therapeutics, Inc. /De/

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (Right to Buy)	77.2K	$137K	$1.78	Dec 16, 2022	Direct	Common Stock
Common Stock	52K	$112K	$2.15	Dec 16, 2022	Direct

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.